NCT00694564

Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children

A Pilot Open-labeled Trial of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Huang, Jeannie, M.D. · Individual
• Sex: All
• Age: 8 Years – 22 Years
• Healthy volunteers: Not accepted

Summary

This pilot study will investigate the efficacy of SAM-e for the treatment of recurrent abdominal pain in children. This will be an open-labeled study and all participants will receive SAM-e therapy. Given that SAM-e has been demonstrated to improve symptoms of depression and pain with minimal side effects as compared to other antidepressant therapy, we hypothesize that SAM-e will reduce pain symptoms among children with recurrent abdominal pain.

Conditions

• Abdominal Pain

Interventions

Type	Name	Description
DRUG	S-adenosyl methionine	S-adenosyl methionine will be dosed as 200 mg tablets with doses ranging from 200 to 1400 mg daily.

Timeline

• Start date: 2007-06-01
• Primary completion: 2011-03-01
• Completion: 2012-07-01
• First posted: 2008-06-10
• Last updated: 2018-03-16
• Results posted: 2013-09-13

Locations

1 site across 1 country: United States